- Global Pharma News & Resources

Global Superdisintegrants Market 2018-2023: Increasing Adoption of Orally Disintegrating Tablets, Growing Generics Market, and the Emergence of New Superdisintegrant

Global Superdisintegrants Market 2018-2023: Increasing Adoption of Orally Disintegrating Tablets, Growing Generics Market, and the Emergence of New Superdisintegrant

PR Newswire

DUBLIN, Sept. 7, 2018

DUBLIN, Sept. 7, 2018 /PRNewswire/ --

The "Superdisintegrants Market by Product, Formulation, Therapeutic Area - Global Forecast to 2023" report has been added to's offering.

The global superdisintegrants market is projected to reach USD 536.5 million by 2023 from USD 366.4 million in 2018, at a CAGR of 7.9%.

Factors contributing to the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and the emergence of new superdisintegrants for the pharmaceutical industry. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth.

The report analyzes the global superdisintegrants market by type, formulation, therapeutic area, and region. By type, the synthetic superdisintegrants segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the extensive consumption of these superdisintegrants in various pharmaceutical drug formulations due to the advantages offered such as effectiveness at lower concentrations as compared to starch and a lesser effect on the compressibility and flowability of the dosage form.

Based on formulation, the tablets segment accounted for the larger share of the global superdisintegrants market in 2017. The large share of this segment can be attributed to tablets being the most widely used dosage forms due to the benefits offered such as stability, low manufacturing cost (as compared to other dosage forms), easy product identification, and compactness, along with the increasing focus on orally disintegrating tablets and fast-dissolving tablets.

Based on therapeutic area, the neurological diseases segment is expected to register the highest CAGR during the forecast period. This can be attributed to the increasing incidences of neurological disorders at the global level along with the growing demand for effective therapies.

Superdisintegrants Market

Geographically, the global superdisintegrants market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, Europe accounted for the largest share of the superdisintegrants market, followed by North America and Asia Pacific. The dominance of the European region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to extensive consumption of excipients. The growing emphasis on superior pharmaceutical products and generics is also expected to aid the market growth in the region.

Safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.

The prominent players in the global superdisintegrants market are

  • Ashland Inc.
  • DowDuPont
  • JRS Pharma
  • DFE Pharma
  • Roquette
  • Asahi Kasei Corporation
  • Merck KGaA
  • Corel Pharma Chem
  • Avantor Performance Materials, LLC

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Superdisintegrants Market Overview
4.2 Superdisintegrants Market: Geographic Growth Opportunities
4.3 Regional Mix: Superdisintegrants Market (2018-2023)
4.4 Synthetic Superdisintegrants Market, By Type and Region (2017)
4.5 Superdisintegrants Market: Developed vs Developing Markets, 2018 vs 2023

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers Growing Adoption of Orally Disintegrating Tablets Growing Generics Market Emergence of New Superdisintegrants for the Pharmaceutical Industry
5.2.2 Market Opportunities Pharmaceutical Market Expansion in Emerging Countries
5.2.3 Market Challenges Safety and Quality Concerns

6 Regulatory Analysis

6.1 Introduction
6.2 North America
6.2.1 US
6.2.2 Canada
6.3 Europe
6.4 Asia Pacific
6.4.1 Japan
6.4.2 China
6.4.3 India

7 Superdisintegrants Market, By Type

7.1 Introduction
7.2 Synthetic Superdisintegrants
7.2.1 Crospovidone
7.2.2 Modified Starch (Sodium Starch Glycolate)
7.2.3 Modified Cellulose Croscarmellose Sodium Low-Substituted Hydroxypropyl Cellulose
7.2.4 Calcium Silicates
7.2.5 Ion Exchange Resins
7.3 Natural Superdisintegrants
7.4 Other Superdisintegrants

8 Superdisintegrants Market, By Formulation

8.1 Introduction
8.2 Tablets
8.3 Capsules

9 Superdisintegrants Market, By Therapeutic Area

9.1 Introduction
9.2 Neurological Diseases
9.3 Gastrointestinal Diseases
9.4 Oncology
9.5 Inflammatory Diseases
9.6 Infectious Diseases
9.7 Cardiovascular Diseases
9.8 Hematological Diseases

10 Superdisintegrants Market, By Region

10.1 Introduction
10.2 Europe
10.2.1 Switzerland
10.2.2 Germany
10.2.3 Italy
10.2.4 France
10.2.5 UK
10.2.6 Spain
10.2.7 Rest of Europe
10.3 North America
10.3.1 US
10.3.2 Canada
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa

11 Competitive Landscape

11.1 Overview
11.2 Competitive Situation and Trends
11.3 Market Share Analysis

12 Company Profiles

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content with multimedia:

SOURCE Research and Markets

Editor Details

Last Updated: 07-Sep-2018